Home › Funds › PRENTISS SMITH & CO INC › QGEN

PRENTISS SMITH & CO INC position in QGEN

QIAGEN NV · Health Care

PRENTISS SMITH & CO INC reported holding 127,055 shares of QGEN (QIAGEN NV) in its Q3 2026 13F filing — a position valued at US$5.6M, representing 3.15% of its reported portfolio and ranking #9 among its reported holdings. PRENTISS SMITH & CO INC has disclosed QGEN holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)127.06K sh
Reported value held$5.56M
Portfolio Weight3.15%
First reportedQ3 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How PRENTISS SMITH & CO INC's QGEN position evolved

PRENTISS SMITH & CO INC first disclosed a stake in QGEN in Q3 2024 at 85,986 shares (US$3.9M). The position peaked in Q3 2026 at 127,055 shares, worth US$5.6M. Across 9 filings, PRENTISS SMITH & CO INC increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 127,055 shares valued at US$5.6M — a reduction of -4,541 shares quarter over quarter.. Notable position changes include a 55% increase in Q1 2026 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 85.99K $3.92M New
Q4 2024 87.58K $3.90M Add
Q1 2025 84.95K $3.41M Reduce
Q2 2025 84.26K $4.05M Reduce
Q3 2025 83.07K $3.71M Reduce
Q4 2025 85.82K $3.86M Add
Q1 2026 133.26K $5.34M Add
Q2 2026 131.60K $5.15M Reduce
Q3 2026 127.06K $5.56M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About QGEN and 13F data

QGEN (QIAGEN NV) is a Health Care company. 28 other funds we track also report a position in QGEN — the largest reported positions include Fivespan Partners, LP (US$237.6M), EARNEST PARTNERS LLC (US$203.6M), Helikon Investments Ltd (US$100.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding QGEN

All QGEN fund holders →

FAQ

How long has PRENTISS SMITH & CO INC held QGEN?

PRENTISS SMITH & CO INC has disclosed QGEN holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is PRENTISS SMITH & CO INC's current position in QGEN?

As of Q3 2026, PRENTISS SMITH & CO INC holds 127.06K shares of QGEN (QIAGEN NV), valued at $5.56M, representing 3.15% of its reported portfolio and ranking #9.

Has PRENTISS SMITH & CO INC been buying or selling QGEN?

In the latest 13F filing (Q3 2026), PRENTISS SMITH & CO INC reduced its position in QGEN. The position peaked in Q3 2026 at 127.06K shares.

Which other funds hold QGEN?

Other major institutional holders of QGEN include Fivespan Partners, LP, EARNEST PARTNERS LLC, Helikon Investments Ltd, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.